Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

Delayed Quote. Delayed  - 04/29 09:59:55 pm
1.38 USD   -3.50%
04/27 Galena Biopharma to Report First Quarter 2016 Financial Results a..
04/26 Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of D..
04/19 Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
1.4(c) 1.39(c) 1.39(c) 1.43(c) 1.38(c) Last
1 559 892 1 235 376 801 385 1 247 608 1 319 910 Volume
-1.41% -0.71% 0.00% +2.88% -3.50% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -41,8 M
Net income 2016 -45,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 2,50 M
EBIT 2017 -23,6 M
Net income 2017 -31,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 104x
Capitalization 260 M
More Financials
Company
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
04/27 Galena Biopharma to Report First Quarter 2016 Financial Results and Provide a..
04/26 GALENA BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial St..
04/26 Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors
04/19 Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the Amer..
04/07 GALENA BIOPHARMA : Other Events (form 8-K)
04/04 MONDAY SECTOR LEADERS : Drugs, Biotechnology Stocks
03/30 GALENA BIOPHARMA : Phase 3 PRESENT Clinical Trial with NeuVax (nelipepimut-S) Ac..
03/29 Galena Biopharma Phase 3 PRESENT Clinical Trial with NeuVax™ (nelipepim..
More news
Sector news : Pharmaceuticals - NEC
04:58a ST JUDE MEDICAL : Abbott is counting on growth turnaround at St. Jude Medical
02:42a CIPLA : Blackburne to interpret for Cipla in Liverpool
04/29DJValeant Holder Sequoia Fund Reopens to New Investors -- 2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04/04 Midday Gainers/ Losers
03/30 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/29 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/24 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/23 Midday Gainers/ Losers


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions